ECO Animal Health Group plc

EAH

GB0032036807

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:01 2024-04-26 am EDT			5-day change	1st Jan Change
107.5 ^GBX	+4.88%		+14.36%	-0.92%

Apr. 25	EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling	AN
Apr. 25	Eco Animal Health Group plc Provides Earnings Guidance for the Year 2024	CI

ECO Animal Health Group plc Announces Resignation of Tony Rawlinson, Non-Executive Director

August 09, 2022 at 02:00 am EDT

ECO Animal Health plc announced that Tony Rawlinson, Non-Executive Director, has resigned from the Board to pursue other business opportunities, with immediate effect.

Latest news about ECO Animal Health Group plc

EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling	Apr. 25	AN
Eco Animal Health Group plc Provides Earnings Guidance for the Year 2024	Apr. 25	CI
ECO Animal Health streamlines product portfolio with disposal	Apr. 04	AN
Eco Animal Health Strikes EUR1.3 Million Deal to Sell Equine Parasites Treatment	Apr. 04	MT
Acme Drugs - S.R.L. acquired ECOmectin® Horsepaste from ECO Animal Health Group plc for £1.1 million.	Apr. 03	CI
EARNINGS AND TRADING: Getech confident; Aukett Swanke makes buy	Mar. 21	AN
ECO Animal Health Group plc Provides Revenue Guidance for the Full Year Ending 31 March 2024	Mar. 21	CI
Eco Animal Health Sees FY Revenue In-Line With Market Expectations	Mar. 21	RE
ECO Animal Health Group plc Appoints Joachim Hasenmaier as Non-Executive Director	Feb. 12	CI
ECO Animal Health gets Ecovaxxin vaccines trademark approval in EU	Feb. 06	AN
ECO Animal Health Group plc Announces the ECOVAXXIN Family in the EU	Feb. 06	CI
Eco Animal Health sells properties for GBP1.1 million total	Jan. 08	AN
Eco Animal Health Group Completes Sale of Former UK Office	Jan. 08	MT
ECO Animal Health swings to first half loss but revenue rises	Nov. 27	AN
ECO Animal Health swings to second half loss but revenue rises	Nov. 27	AN
Earnings Flash (EAH.L) ECO ANIMAL HEALTH GROUP Posts Fiscal H1 Revenue GBP38M	Nov. 27	MT
ECO Animal Health Group plc Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 27	CI
Shore Capital Begins Eco Animal Health Coverage at Buy Rating	Nov. 17	MT
Shore cuts Sage; Barclays raises NatWest	Nov. 17	AN
ECO Animal Health up on new US and Canada label claim for Aivlosin	23-10-24	AN
ECO Animal Health Gains New Label Indication for Pig Antibiotic in US, Canada	23-10-24	MT
ECO Animal Health Group plc Announces New USA and Canada Label Claim for Aivlosin®	23-10-24	CI
FTSE 100 Closes Up 0.2% Lifted by Oil Stocks	23-07-10	DJ
UK Long-Dated Gilt-Yields Rising Fast, Inverted Gilt Yield Curve Flattens	23-07-10	DJ
ECO Animal Health shares up on "strong" annual performance	23-07-10	AN

Chart ECO Animal Health Group plc

Duration

Period

More charts

ECO Animal Health Group plc is a United Kingdom-based animal health biotechnology company. The Company is engaged in the manufacturing and supplying of animal health products globally. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. It provides quality products for swine and poultry, primarily anti-infectives. The Companyâs segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. The Company research, develops and commercializes products for livestock. The Companyâs lead product, Aivlosin, is an antimicrobial which is used under veterinary prescription for the treatment of economically important respiratory and gastrointestinal diseases in pigs and poultry. The Company is also engaged in researching and developing new solutions to enhance the lives of pigs and poultry.

Sector

Pharmaceuticals

Calendar

2024-06-30 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ECO Animal Health Group plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.075 GBP

Average target price

1.851 GBP

Spread / Average Target

+72.21%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
ECO ANIMAL HEALTH GROUP PLC	-0.92%	86.76M
ZOETIS INC.	-19.73%	70.08B
ELANCO ANIMAL HEALTH INCORPORATED	-11.01%	6.43B
BLUESTAR ADISSEO COMPANY	+15.88%	3.52B
VIRBAC	-2.92%	3.11B
VIMIAN GROUP AB	-0.68%	1.38B
JINYU BIO-TECHNOLOGY CO., LTD.	-17.27%	1.37B
VETOQUINOL SA	-2.73%	1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD	-14.67%	1.13B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-5.37%	1.02B

Veterinary Drugs